The 20 Best Arthritis Doctors Near Me in Baltimore, MD

Dr. Ana-Maria Orbai is an Associate Professor of Medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and psoriatic arthritis. Dr. Orbai earned her M.D. from the Iuliu Hatieganu School of Medicine and Pharmacy, Cluj-Napoca, in Romania. She completed internship and residency training in internal medicine at the Johns Hopkins University-Sinai Hospital program. Subsequently, Dr. Orbai completed her post-doctoral fellowship training in rheumatology at Johns Hopkins. During her fellowship she earned her Master in Health Sciences degree in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Orbai directs the Psoriatic Arthritis Program in the Johns Hopkins Arthritis Center. Her clinical focus is psoriatic arthritis and spodyloarthritis. Dr. Orbai's research aims to understand psoriatic disease subtypes and improve treatment strategies for people with psoriatic arthritis. Dr. Orbai was awarded a Rheumatology Research Foundation Scientist Development award in 2014 and a Jerome L Greene Foundation Scholar award in 2018. Dr. Orbai is rated as an Elite provider by MediFind in the treatment of Arthritis. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Psoriatic Arthritis, Psoriasis, Arthritis, and Rheumatoid Arthritis (RA). Dr. Orbai is board certified in American Board Of Internal Medicine.

Marc Hochberg is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Hochberg is rated as an Elite provider by MediFind in the treatment of Arthritis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Arthritis, Osteoporosis, Rheumatoid Arthritis (RA), Knee Replacement, and Hip Replacement.

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is rated as a Distinguished provider by MediFind in the treatment of Arthritis. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Tenotomy, and Osteotomy. Dr. Petri is board certified in American Board Of Internal Medicine and American Board Of Allergy And Immunology.

Dr. Clifton Bingham is a Professor of Medicine, Director of the Johns Hopkins Arthritis Center, Director of the Center for Patient-Centered Outcomes Research in Rheumatology, Deputy Director for Research in the Division of Rheumatology, and Co-Director of the Rheumatic Diseases Research Core Center. He received his M.D. from Columbia University, where he also completed his Internal Medicine residency. He trained as a Fellow in both Rheumatology and in Allergy and Clinical Immunology at the Brigham and Women’s Hospital. Before coming to Hopkins in 2005, he was on faculty at NYU Hospital for Joint Diseases, where he founded a pioneering clinical and translational research center in rheumatology. He now directs the Johns Hopkins Arthritis Center, a group of 8 rheumatologists, 2 nurses, and a large clinical and research staff that sees more than 4500 patient visits each year, an integrates research with clinical care. His clinical interests are in the care of people living with Rheumatoid Arthritis (RA) and other forms of inflammatory arthritis. Dr. Bingham’s research experience has been diverse, and across the research continuum from bench to bedside. His early work focused on understanding the cytokine regulation of inflammatory mediator generation operative in rheumatologic and allergic diseases. He conducted prior translational research to better understand the role of initiating and amplifying pathways in RA, and has ongoing collaborations with several basic researchers to identify biomarkers for improved patient phenotyping and outcome prediction. Additional multidisciplinary clinical and translational work has focused on the role of periodontal disease and oral bacteria as triggers of RA. In the realm of clinical research, he has served as principal investigator and helped to design and analyze a number of NIH and industry-sponsored clinical trials of multiple agents in early to late phases of development for RA, psoriatic arthritis, and osteoarthritis. He has led several studies of the effects of biological and immunomodulatory therapies on responses to immunizations. A large amount of his current research is focused in the area of patient centered outcomes research, including patient reported outcome development, validation, and integration in clinical care. He serves as a member of the Executive Leadership Committee for the international Outcome Measures in Rheumatology (OMERACT) methodology group. He has authored more than 170 original research articles, reviews, and editorials, and 12 book chapters. He served as a Co-Editor for the journal of the American College of Rheumatology, Arthritis and Rheumatology, and as a reviewer for a number of rheumatology journals and national and international grant reviews. Dr. Bingham is rated as a Distinguished provider by MediFind in the treatment of Arthritis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Myositis, and Psoriatic Arthritis. Dr. Bingham is board certified in American Board Of Internal Medicine.

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Arthritis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis. Dr. Baer is board certified in American Board Of Internal Medicine.

Dr. Laura Cappelli is an Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and adverse effects from cancer immunotherapy. Dr. Cappelli earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and performed a fellowship in rheumatology at the Johns Hopkins Hospital. She has a MHS in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Cappelli focuses on immune related adverse events due to cancer immunotherapy and all forms of inflammatory arthritis. She co-directs the Immune-related toxicity team which provides clinical, research and educational support for immune related adverse events. Her primary research interest is inflammatory arthritis due to immune checkpoint inhibitor therapy. She also studies rheumatoid arthritis. Dr. Cappelli is rated as a Distinguished provider by MediFind in the treatment of Arthritis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Arthritis, Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis. Dr. Cappelli is board certified in American Board Of Internal Medicine.

Dr. Allan Gelber is Professor of Medicine and Deputy Director for Education and Faculty Development in the Division of Rheumatology. He holds a joint appointment in the Department of Epidemiology at the Bloomberg School of Public Health and is Associate Faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research. Dr. Gelber is a graduate of the Johns Hopkins University School of Medicine and received both his MPH and PhD degrees (the latter in Clinical Investigation) at the Bloomberg School. He pursued internship and residency training in internal medicine at Duke University and then undertook his fellowship training in rheumatology at Johns Hopkins. Dr. Gelber has had an active role as an Educator in the Rheumatic Diseases. He previously served as Fellowship Program Director at Johns Hopkins from 2001-2011. Thereafter, he shifted his primary educational focus from rheumatology fellows to medical students, and to internal medicine housestaff on the Bayview and Johns Hopkins campuses. He directs the Musculoskeletal Section of the Genes-to-Society Course to the 2nd year medical school class. Currently, Dr. Gelber serves as Thayer Firm Faculty Leader of the Osler Medical Training Program. and among the Aliki Scholars at Johns Hopkins Bayview Medical Center. Dr. Gelber chairs the M.D. Admissions Committee at the School of Medicine. Dr. Gelber is rated as an Advanced provider by MediFind in the treatment of Arthritis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Gout, Arthritis, Scleroderma, Knee Replacement, and Endoscopy. Dr. Gelber is board certified in American Board Of Internal Medicine.

Dr. Maximilian Konig is an Assistant Professor of Medicine in the Division of Rheumatology and Director of the Cellular Therapy Program (Autoimmunity) in the Department of Medicine at the Johns Hopkins University School of Medicine. He received his medical degree from Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin (Germany) and completed his residency training in the Stanbury Physician-Scientist Pathway at Massachusetts General Hospital, Harvard Medical School. Dr. Konig concluded subspecialty training in Clinical and Molecular Rheumatology as well as Advanced Rheumatology at Johns Hopkins Hospital. His clinical interests lie in treating patients with systemic autoimmune diseases, including myositis, scleroderma, lupus, vasculitis, and inflammatory arthritis. Dr. Konig is rated as an Advanced provider by MediFind in the treatment of Arthritis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Systemic Lupus Erythematosus (SLE), and Periodontitis. Dr. Konig is board certified in American Board Of Internal Medicine.

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is rated as an Advanced provider by MediFind in the treatment of Arthritis. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, and Scleroderma. Dr. Paik is board certified in American Board Of Internal Medicine.

Dr. Uzma Haque is an Assistant Professor of Medicine at the Arthritis Center at The Hopkins Bayview Medical Center, and is actively engaged in clinical care to patients with general rheumatic and musculoskeletal disorders. Dr. Haque is rated as an Advanced provider by MediFind in the treatment of Arthritis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, and Psoriasis. Dr. Haque is board certified in American Board Of Internal Medicine.

Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is rated as an Advanced provider by MediFind in the treatment of Arthritis. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis. Dr. Christopher is board certified in American Board Of Internal Medicine.

Dr. Khaled Kebaish serves as chief of the Spine Division in the Department of Orthopaedic Surgery. He is a professor of orthopaedic surgery and neurological surgery at the Johns Hopkins University School of Medicine. His areas of clinical expertise include spine deformities and scoliosis, degenerative spine disorders, spine tumors and disc arthroplasty. Dr. Kebaish earned his M.D. from Cairo University. He completed his residency at University of Toronto in Toronto, Canada, and performed a fellowship in spinal reconstructive surgery at Johns Hopkins. Dr. Kebaish's research interests include the clinical and functional outcomes of spine surgery with a special focus on adult deformity surgery. He also focuses on the biomechanical testing and evaluation of different fixation devices and techniques in the adult spine. Dr. Kebaish is rated as an Experienced provider by MediFind in the treatment of Arthritis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Kyphosis, Lordosis, Scoliosis, Osteotomy, and Spinal Fusion. Dr. Kebaish is board certified in American Board Of Orthopaedic Surgery.

Andrea Fava is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Fava is rated as an Experienced provider by MediFind in the treatment of Arthritis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Scleroderma, and Systemic Sclerosis (SSc). Dr. Fava is board certified in American Board Of Internal Medicine.

Colonel James Ficke, M.D., is Robert A. Robinson Professor of Orthopaedic Surgery at the Johns Hopkins School of Medicine and director of the Department of Orthopaedic Surgery. He is also orthopaedist-in-chief of The Johns Hopkins Hospital. He is nationally renowned as an expert on the treatment of complex foot and ankle patients, lower extremity trauma patients and amputees. Dr. Ficke received his M.D. from Uniformed Services University of Health Sciences in 1987. He completed a transitional internship at Madigan Army Medical Center, and finished his residency in orthopaedic surgery at Tripler Army Medical Center. He also completed an AO fellowship in Trauma in Munich Germany, and a foot and ankle fellowship in Dallas, Texas. Prior to his current position, Dr. Ficke was chairman of the Department of Orthopaedics and Rehabilitation at the San Antonio Military Medical Center. He also served the U.S. Army Surgeon General as the senior advisor on policy and personnel for orthopaedics and extremity injuries for seven years. During his deployment as deputy commander of clinical services at the 228th Combat Support Hospital in Mosul, Iraq, from 2004 to 2005, he was the senior orthopedic surgeon, treating more than 600 U.S. soldiers and Iraqi patients for war injuries. Dr. Ficke has received numerous awards for his skills as a surgeon and educator, as well as two dozen military decorations and awards including the Bronze Star and Meritorious Service Medals. His service earned him the Society of Military Orthopaedic Surgeons’ prestigious 2010 Colonel Brian Allgood Memorial Leadership Award, and The Surgeon General's 2010 Major General Lewis Aspey Mologne Award. He has served as the co-chair of the Extremity War Injury Symposium sponsored by the American Academy of Orthopaedic Surgeons since 2005. Dr. Ficke is rated as an Experienced provider by MediFind in the treatment of Arthritis. His clinical expertise encompasses Osteoarthritis, Ear Barotrauma, Contracture Deformity, Fasciotomy, and Hip Replacement. Dr. Ficke is board certified in American Board Of Orthopaedic Surgery.

Brock Lindsey, M.D., is an orthopaedic surgeon specializing in orthopaedic oncology. He treats children and adults with all types of bone and soft tissue sarcomas. Dr. Lindsey has expertise in nanoparticle delivery of immunotherapy, immunodiagnostics as a novel treatment for osteosarcoma, as well as complex reconstruction after amputation, including osseointegration. Dr. Lindsey earned his medical degree from the University of Cincinnati. He then completed an orthopaedic surgery residency at West Virginia University’s (WVU) J.W. Ruby Memorial Hospital, becoming the department’s first to complete a research fellowship during residency. Dr. Lindsey also pursued a fellowship in musculoskeletal oncology at the University of Pittsburgh Medical Center (UPMC) and UPMC Children’s Hospital before returning to WVU Medicine as an attending physician. During his 12 years at WVU Medicine, Dr. Lindsey created programs in musculoskeletal oncology and adult reconstruction as well as a multidisciplinary amputation clinic. He also led a musculoskeletal research laboratory into the national rankings for federal funding for orthopaedic surgery departments. His research focuses on improving treatment strategies for metastatic osteosarcoma and exploring human/machine interfaces for amputees. His work has been published in local, national and international basic science and clinical research journals. Dr. Lindsey has experience mentoring and training students at all levels from undergraduate and graduate students to postdoctoral positions. He won Press Ganey’s “Top Provider” award every year between 2013 and 2018. He also founded ICaPath, a biotech startup derived from his laboratory research that is currently working toward a first in-human clinical trial. Videos Brock Lindsey, M.D.Orthopaedic Oncologist OsseointegrationQ&A with Dr. Brock Lindsey. Dr. Lindsey is rated as an Experienced provider by MediFind in the treatment of Arthritis. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Adult Soft Tissue Sarcoma, Osteosarcoma, Leg or Foot Amputation, and Hip Replacement. Dr. Lindsey is board certified in American Board Of Orthopaedic Surgery.

Julia Shalen is a Pediatric Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Shalen is rated as an Experienced provider by MediFind in the treatment of Arthritis. Her clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Juvenile Dermatomyositis, and Arthritis. Dr. Shalen is board certified in American Board Of Pediatrics.

Dr. Greg Osgood is an assistant professor of orthopaedic surgery at the Johns Hopkins School of Medicine and Chief of Orthopaedic Trauma for the Department of Orthopaedic Surgery. His areas of expertise include orthopaedic trauma, with a special focus on fracture non-unions, pelvis and acetabular injuries, and fractures and surgical infections. Dr. Osgood’s undergraduate degree is from Harvard University. He completed medical school at Columbia University College of Physicians and Surgeons in New York. Dr. Osgood began his orthopaedic residency training with the United States Air Force and completed this training at New York Orthopaedic Hospital at the Columbia Presbyterian Medical Center. In 2005, he completed an Orthopaedic Trauma Fellowship at Harborview Medical Center in Seattle. He joined the Johns Hopkins faculty in 2010 as the organization''s first orthopaedic trauma faculty member. Dr. Osgood’s interests in orthopaedic trauma care include fracture non-unions, pelvis and acetabular injuries, routine fractures and surgical infections. Dr. Osgood is a former major in the United States Air Force. He completed several combat deployments, providing orthopaedic trauma care to our military. Dr. Osgood is actively involved in numerous professional organizations, including being the associate editor of the Journal of Orthopaedic Trauma, a member of the AO North America Teaching Faculty, a member of the Education Committee of the Osteosynthesis and Trauma Care Foundation, Orthopaedic Trauma Association Military Committee, and the director of the Humanitarian Program of the Osteosynthesis and Trauma Care Foundation. Videos Dr. Greg OsgoodOrthopaedic Trauma Surgeon An Innovative Approach to Nerve Repair ‚Äî Santi‚Äôs Story. Dr. Osgood is rated as an Experienced provider by MediFind in the treatment of Arthritis. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Acute Pain, Infectious Arthritis, Compartment Syndrome, Hip Replacement, and Vertebroplasty. Dr. Osgood is board certified in American Board Of Orthopaedic Surgery.

Dr. Antony Rosen was an Osler resident and rheumatology fellow at Johns Hopkins Hospital before joining the faculty at Johns Hopkins, where he was appointed a professor in 2002. He served as director of the Division of Rheumatology between 2002 and 2022, overseeing a substantial expansion in the fellowship program and building the faculty from 14 to 26, and has been the Vice Dean for Research since 2013. Dr. Rosen received his medical degree from the University of Cape Town in South Africa in 1984 with first-class honors. After completing his internship in medicine & surgery and a year of postdoctoral study in medical biochemistry, he joined Dr. Alan Aderem at the Rockefeller University to pursue postdoctoral studies in immunology and cellular biology. Dr. Rosen is rated as an Experienced provider by MediFind in the treatment of Arthritis. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Polymyositis, Scleroderma, and Systemic Sclerosis (SSc). Dr. Rosen is board certified in American Board Of Internal Medicine.

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as an Experienced provider by MediFind in the treatment of Arthritis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma. Dr. Wigley is board certified in American Board Of Internal Medicine.

Dr. Philip Seo is an Associate Professor in the Division of Rheumatology. A graduate of Harvard College and the College of Physicians and Surgeons at Columbia University, Dr. Seo completed his Internal Medicine training as a member of the Osler Medical Service at the Johns Hopkins Hospital. Since then, he has worked at Johns Hopkins in several capacities, including as a hospitalist at Johns Hopkins Bayview Medical Center, and as an Assistant Chief of Service of the Department of Medicine at the Johns Hopkins Hospital, before joining the Division of Rheumatology. Dr. Seo is the Director of the Johns Hopkins Vasculitis Center and Director of the Johns Hopkins Rheumatology Fellowship Program. His clinical interests lie in the assessment and treatment of patients with systemic vasculitis, in particular, the ANCA-associated vasculitides, which include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. Dr. Seo is rated as an Experienced provider by MediFind in the treatment of Arthritis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Seo is board certified in American Board Of Internal Medicine.